Quick Answer
Bioventus Inc. reported Operating Income of $53.98 million for fiscal year 2025.
Bioventus Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $53.98M | +455.2% |
| 2024 | -$15.20M | +81.4% |
| 2023 | -$81.72M | +51.1% |
| 2022 | -$167.23M | -1486.6% |
| 2021 | $12.06M | -43.2% |
| 2020 | $21.24M | -31.9% |
| 2019 | $31.19M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.25M | +208.5% | -38.7% |
| June 30, 2025 | $18.37M | +158.4% | +277.2% |
| March 31, 2025 | $4.87M | -1.2% | +33.5% |
| September 30, 2024 | $3.65M | +50.8% | +111.6% |
| June 30, 2024 | -$31.47M | -566.3% | -738.7% |
| March 31, 2024 | $4.93M | +105.4% | +103.8% |
| September 30, 2023 | $2.42M | +101.9% | -64.2% |
| June 30, 2023 | $6.75M | +304.1% | +107.3% |
- Bioventus Inc. showed an increase of +455.2% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Bioventus Inc.’s operating income has grown by 73.0% (from $31.19 million to $53.98 million).
- The most recent figure is from Bioventus Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: